Sms Pharmaceuticals Ltd.

SMSPHARMA NSE Healthcare Pharmaceuticals
₹463.45
+11.02%
Delayed · cached 15 min

Fair value analysis

SMSPHARMA
Sms Pharmaceuticals Ltd.
Healthcare›Pharmaceuticals
₹417.45
Close used for this calculation
₹241.50Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
34/100
Profitability15/25
Returns6/25
Balance Sheet9/25
Efficiency4/25
Growth3/25
Weak
Quality radar
34Prof.15/25Ret.6/25Eff.4/25B.Sht9/25Growth3/25

Consensus fair value

₹241.50
Above FV
▼ -42.1% against the close used
Model range ₹88.21 – ₹388.77
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear₹88.21Fair value₹241.50Bull₹388.77
FairClose
52-week traded range
52W low ₹244.3052W high ₹438.30

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading above the consensus fair value

Sms Pharmaceuticals Ltd. closed at ₹417.45, 72.9% above the consensus fair value of ₹241.50 drawn from 9 valuation models.

Financial DNA score 34/100 — Weak. P/E of 42.4x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation
₹205.28
-50.8%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8.1%, r=10%, tg=3%, n=10yr
Graham Number
₹136.37
-67.3%
√(22.5 × EPS × BVPS)
EPS=10.89, BVPS=75.9 · outside Graham range (P/E 42.4, P/B 5.5) — asset-light, treat as a rough floor
Graham Formula
₹249.77
-40.2%
EPS × (8.5 + 2g) × 6.5 ÷ FD_Rate
g=8.1%, FD=7%
P/E Fair Value
₹388.77
-6.9%
EPS × 35.7x (sector P/E)
EPS=10.89, Sector P/E=35.7x
Peter Lynch (PEG)
₹88.21
-78.9%
EPS × Growth% (PEG = 1 is fair)
EPS=10.89, g=8.1%
EV/EBITDA
₹250.04
-40.1%
(EBITDA × 14.1x − Net Debt) ÷ Shares
EBITDA=2.11B
Book Value (P/B)
₹157.49
-62.3%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=75.9, ROE=14.3%, g=6%, r=10%
Reverse DCF
₹417.45
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 15.9% | Historical: 8.1%
Margin of Safety
₹183.79
-56.0%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=245.05, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Educational data only. Not a recommendation to buy, sell or hold any security.